Back in June 2017, CDER and the Office of Regulatory Affairs (ORA) signed a “Concept of Operations” (ConOps) white paper laying out how the two would divide responsibility for drug facility evaluations and inspections. Nearly a decade, one major reorganization, and a lot of remote-assessment …
Menu